Latest News

Gedatolisib showed promising ORRs when given in combination with darolutamide and trastuzumab biosimilar in mCPRC and mBC, respectively.
Early Efficacy Seen With Gedatolisib-Based Therapies Prostate/Breast Cancers

June 30th 2025

Deciding when to use immunotherapy and how to utilize antibody-drug conjugates are complicated processes that require multidisciplinary collaboration to ensure that all patients with breast cancer receive appropriate and efficient care.
The Proper Ways to Identify and Use ADCs in Breast Cancer Subtypes

June 29th 2025

More News